205 related articles for article (PubMed ID: 29284499)
1. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
[TBL] [Abstract][Full Text] [Related]
2. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
3. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
4. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
[TBL] [Abstract][Full Text] [Related]
5. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
Vigneault DM; Yang E; Jensen PJ; Tee MW; Farhad H; Chu L; Noble JA; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Ho CY; Bluemke DA
Radiology; 2019 Mar; 290(3):640-648. PubMed ID: 30561279
[TBL] [Abstract][Full Text] [Related]
6. Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.
Chung H; Kim Y; Park CH; Kim IS; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
Cardiovasc Ultrasound; 2021 Jan; 19(1):4. PubMed ID: 33407484
[TBL] [Abstract][Full Text] [Related]
7. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
Germans T; Rüssel IK; Götte MJ; Spreeuwenberg MD; Doevendans PA; Pinto YM; van der Geest RJ; van der Velden J; Wilde AA; van Rossum AC
J Cardiovasc Magn Reson; 2010 Mar; 12(1):13. PubMed ID: 20230637
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.
Tarkiainen M; Sipola P; Jalanko M; Heliö T; Laine M; Järvinen V; Häyrinen K; Lauerma K; Kuusisto J
J Cardiovasc Magn Reson; 2016 Jun; 18(1):33. PubMed ID: 27259862
[TBL] [Abstract][Full Text] [Related]
9. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
[TBL] [Abstract][Full Text] [Related]
10. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
12. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
Hinojar R; Zamorano JL; Fernández-Méndez M; Esteban A; Plaza-Martin M; González-Gómez A; Carbonell A; Rincón LM; Nácher JJJ; Fernández-Golfín C
Int J Cardiovasc Imaging; 2019 Jun; 35(6):1055-1065. PubMed ID: 30706353
[TBL] [Abstract][Full Text] [Related]
15. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
Kim KJ; Choi HM; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Zo JH; Sohn DW
PLoS One; 2016; 11(6):e0157433. PubMed ID: 27336444
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
[TBL] [Abstract][Full Text] [Related]
17. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
[TBL] [Abstract][Full Text] [Related]
18. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
[TBL] [Abstract][Full Text] [Related]
19. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
